Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-03-13
2007-03-13
Morris, Patricia L. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S273700
Reexamination Certificate
active
11095547
ABSTRACT:
Crystals of (S)-2[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole or salts thereof, useful as excellent antiulcer drugs.
REFERENCES:
patent: 4628098 (1986-12-01), Nohara et al.
patent: 6462058 (2002-10-01), Fujishima et al.
patent: 6608092 (2003-08-01), Fujishima et al.
patent: 2001/0025107 (2001-09-01), Barberich et al.
patent: 0 174 726 (1986-03-01), None
patent: 0 302 720 (1989-02-01), None
patent: 96/02535 (1996-02-01), None
patent: 96/17077 (1996-06-01), None
patent: 97/02261 (1997-01-01), None
patent: 98/21201 (1998-05-01), None
patent: 9 208 716 (1999-05-01), None
patent: 99/38512 (1999-08-01), None
patent: 99/56698 (1999-11-01), None
Ulicky et al., “Comprehensive Dictionary of Physical Chemistry”, NY:Prentice Hall, 1992, p. 21.
H. Nagaya et al., “Effects of the Enantiomers of Lansoprazole (AG-1749) on (H++K+)-ATPase Activity in Canine Gastric Microsomes and Acid Formation in Isolated Canine Parietal Cells”, Biochemical Pharmacology, vol. 42, No. 10. pp. 1875-1878, 1991.
H. Katsuki et al., “Determination of R(+)- and S(−)-Lansoprazole Using Chiral Stationary-Phase Liquid Chromatography and Their Enantioselective Pharmacokinetics in Humans”, Pharmaceutical Research, vol. 13, No. 4, pp. 611-615, 1996.
CA 127:336721, Curin et al., 1997.
CA 127:362535, Vrecer et al., 1997.
Chemical & Engineering News, Feb. 2003.
U.S. Pharmacopia, 1995, pp. 1843-1844.
Concise Encyclopedia Chemistry, pp. 872-873, 1993.
Chemical Abstract CA 125:185465 of article of: B. I. Hirschowitz, “Long-term treatment with iansoprazole for patients with Zolliger-Ellison syndrome,”Alimentary Pharmacology and Therapeutics, vol. 10, No. 4, pp. 507-522, 1996.
B. I. Hirschowitz et al., “Long-term treatment with Iansoprazole for patients with Zollinger-Ellison syndrome,” Alimentary Pharmacology and Therapeutics, vol. 10, No. 4, pp. 507-522, 1996.
Aoki Isao
Fujishima Akira
Kamiyama Keiji
Morris Patricia L.
Takeda Pharmaceutical Company Limited
Wenderoth Lind & Ponack LLP
LandOfFree
Crystals of benzimidazole compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystals of benzimidazole compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystals of benzimidazole compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3755235